Veronique C. Raimond

Maisons-les-soulaines, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Economic burden estimation to inform prevention policies against emerging zoonotic diseases: The case of tick-borne encephalitis in France.

Economic burden estimation to inform prevention policies against emerging zoonotic diseases: The case of tick-borne encephalitis in France.

Journal: Public health
Published: February 12, 2026

Expert Elicitation on Exposure to Tick Bites and Tick-Borne Encephalitis Risk in Occupational and Recreational Forest Activities.

Expert Elicitation on Exposure to Tick Bites and Tick-Borne Encephalitis Risk in Occupational and Recreational Forest Activities.

Journal: Viruses
Published: December 01, 2025

From bites to ripple effects: Unraveling the health, economic, and social effects of arboviral epidemics in Mainland France.

From bites to ripple effects: Unraveling the health, economic, and social effects of arboviral epidemics in Mainland France.

Journal: IJID regions
Published: October 23, 2025

Estimating Rebates and Other Discounts Received by Medicare Part D.

Estimating Rebates and Other Discounts Received by Medicare Part D.

Journal: JAMA health forum
Published: June 04, 2021

Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.

Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.

Journal: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Published: May 10, 2021

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.

Journal: The Milbank quarterly
Published: March 22, 2021

How much does the hospital stay for infusion of anti-CD19 CAR-T cells cost to the French National Health Insurance?

How much does the hospital stay for infusion of anti-CD19 CAR-T cells cost to the French National Health Insurance?

Journal: Bulletin du cancer
Published: February 07, 2021

Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health.

Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health.

Journal: Bulletin du cancer
Published: January 29, 2021

ETHICS EVALUATION REVEALING DECISION-MAKER MOTIVES: A CASE OF NEONATAL SCREENING.

ETHICS EVALUATION REVEALING DECISION-MAKER MOTIVES: A CASE OF NEONATAL SCREENING.

Journal: International journal of technology assessment in health care
Published: April 11, 2018

Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs.

Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: March 27, 2018

Haute Autorite de sante opinion on cost-effectiveness of health products : results and perspectives

Haute Autorite de sante opinion on cost-effectiveness of health products : results and perspectives

Journal: Sante publique (Vandoeuvre-les-Nancy, France)
Published: January 12, 2016

Online dissemination of clinical practice guidelines as narrative texts and structured pathways: a case study with the treatment of type 2 diabetes.

Online dissemination of clinical practice guidelines as narrative texts and structured pathways: a case study with the treatment of type 2 diabetes.

Journal: Studies in health technology and informatics
Published: August 28, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026